Skip to content

Comparing BlueDop Vascular Expert to Ankle-Brachial Index in the Identification of Peripheral Vascular Disease

Comparing BlueDop Vascular Expert to Ankle-Brachial Index in the Identification of Peripheral Vascular Disease in All-comers and Diabetic Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06436001
Enrollment
104
Registered
2024-05-30
Start date
2023-03-01
Completion date
2024-03-01
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Peripheral Arterial Disease

Keywords

peripheral arterial disease, ankle brachial index, arterial duplex, Doppler waveform

Brief summary

To compare the screening capabilities of the BlueDop Vascular Expert (BVE) and ankle brachial index (ABI) in peripheral arterial disease for all-comer patients and those with diagnosed diabetes mellitus.

Detailed description

This retrospective and prospective single-center study to compare the accuracy and screening capabilities of BVE and ABI with that of conventional Full Leg Arterial Duplex (FLAD) was performed at a private clinic in Sioux Falls, South Dakota, USA, with data collected from March 2023 to March 2024. Currently, BVE carries the European CE Mark but does not yet have FDA approval for use in the United States. This study was undertaken with local IRB approval. Patients 18 years or older who presented to the center were consented to have BVE, ABI, and FLAD performed. BVE examination of lower extremity arteries were performed following the instruction for use (IFU). All examinations were performed by the same two registered vascular technologists. FLAD ultrasound was carried out with waveform interpretation interpreted by an outside cardiothoracic surgeon who specializes in treatment of arterial disease to determine the presence or absence of disease.

Interventions

None listed

Sponsors

Dakota Vascular
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients 18 years or older who presented to the center were consented to have BVE, ABI, and FLAD performed.

Exclusion criteria

* Patients were excluded who had incomplete or inadequate data, if they were known to be currently pregnant, or if they had contraindications to Doppler ultrasound.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivitydata collected from March 2023 to March 2024Comparing ABI and BVE findings to FLAD
Specificitydata collected from March 2023 to March 2024Comparing ABI and BVE findings to FLAD
Accuracydata collected from March 2023 to March 2024Comparing ABI and BVE findings to FLAD
Cohen's Kappa coefficientdata collected from March 2023 to March 2024Comparing ABI and BVE findings to FLAD

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026